Back to Results
First PageMeta Content
Anticonvulsants / Topiramate / Treatment of bipolar disorder / Pharmacology / Ortho-McNeil-Janssen / Ortho-McNeil Pharmaceutical / Food and Drug Administration / Pregnancy / Johnson & Johnson / Medicine / Chemistry


March 4, 2011: Notice on FDA Announcement Regarding TOPAMAX® (topiramate) The Food and Drug Administration (FDA) has announced increased precautions on the use of TOPAMAX in pregnancy. As the makers of TOPAMAX, Ortho-Mc
Add to Reading List

Document Date: 2011-03-04 17:07:37


Open Document

File Size: 216,00 KB

Share Result on Facebook
UPDATE